BCTXZ

BriaCell Therapeutics Corp. Warrant BCTXZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BCTXZ NKGN NCEL XRTX ELAB WINT VRAX AIMD DRMA ATXI
6M -61.76 % -80.00 % -89.21 % -31.26 % -68.65 % -92.98 % -50.91 % -16.60 % 216.66 % 118.21 %
YTD -70.23 % -92.76 % -88.07 % -48.72 % -96.28 % -99.76 % -82.36 % -15.60 % 53.96 % -66.22 %
1Y -70.23 % -92.22 % -86.87 % -46.43 % -96.47 % -99.75 % -79.70 % -10.21 % 73.98 % -63.78 %
3Y -70.23 % -99.12 % -99.48 % -90.87 % -99.99 % -100.00 % -93.22 % -86.60 % -94.99 % -99.34 %
5Y -70.23 % -99.12 % -99.78 % -97.88 % -99.99 % -100.00 % -99.79 % -96.32 % -99.83 % -99.99 %
10Y -70.23 % -99.12 % -99.78 % -97.88 % -99.99 % -100.00 % -99.79 % -96.32 % -99.83 % -99.99 %
From the beginning -70.23 % -99.12 % -99.78 % -97.88 % -99.99 % -100.00 % -99.79 % -96.32 % -99.83 % -99.99 %

Dividend

XORTX Therapeutics Inc.